Cascade Clinic | |
1220 Main St Ste 400, Vancouver, WA 98660-2963 | |
(360) 230-8557 | |
(888) 915-0898 |
Full Name | Cascade Clinic |
---|---|
Type | Facility |
Speciality | Clinic/center - Hearing And Speech |
Location | 1220 Main St Ste 400, Vancouver, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063175644 | NPI | - | NPPES |
1063175644 | Other | OR | REGENCE BCBS |
1346591153 | Medicaid | WA | |
1063175644 | Other | MODA | |
1063175644 | Other | UNITED HEALTH CARE | |
1063175644 | Other | WA | PREMERA |
1063175644 | Other | WA | CIGNA |
1063175644 | Other | WA | KAISER |
1063175644 | Other | WA | AETNA |
1063175644 | Other | REGENCE | |
1063175644 | Other | WA | PACIFIC SOURCE |
1063175644 | Medicaid | WA | |
1063175644 | Other | WA | TRICARE WEST |
1346591153 | Other | WA | TRICARE WEST |
1346591153 | Other | OR | REGENCE BCBS |
Mailing Address | Practice Location Address |
---|---|
Cascade Clinic 1220 Main St Ste 400, Vancouver, WA 98660-2963 Ph: (360) 230-8557 | Cascade Clinic 1220 Main St Ste 400, Vancouver, WA 98660-2963 Ph: (360) 230-8557 |
News Archive
Evotec AG today announced that it has entered into a collaboration with Apeiron Biologics AG, to initially identify small molecule modulators of DREAM (Downstream Regulatory Element Antagonistic Modulator), a novel target involved in perception of various pain mechanisms. Further projects will be evaluated to potentially expand this cooperation in due course.
The Cryogenic Institute of New England, Inc. is pleased to announce the completed transition to 78 Chilmark Street, Worcester, MA 01604. The new facility is located just off of Shrewsbury Street in Worcester. The new facility boasts nearly 5,000 square feet of total area, allowing the Cryogenic Institute to expand its operations.
The firestorm that followed the November 2009 release of guidelines that would have reduced use of screening mammograms in women aged 40 to 49 highlights challenges for implementing the findings of comparative effectiveness research, according to a new analysis. Meeting such challenges - which may become more common due to increased funding for CER - requires better communication to the public and stakeholders about evidence and its connection to health care quality and efficiency.
National bans on highly hazardous pesticides can be a cost-effective and affordable intervention for reducing suicide deaths in countries with a high burden of suicides attributable to pesticides, according to a new study published in The Lancet Global Health today.
A faulty gene linked to a rare blood vessel disorder has led investigators to discover a mechanism involved in determining the fate of possibly thousands of proteins working inside cells.
› Verified 4 days ago